ECONOMIC ENVIRONMENT THE ACTIVITIES OF PHARMACEUTICAL ORGANIZATIONS
Pharmaceutical business in modern conditions is for entrepreneurs and investors a very attractive and promising area of activity that requires further comprehensive research in the field of Economics and management.
E. Manvelyan, R. Petinov, M. Manvelyan
doaj
Aim. The use of mycophenolic acid (MPA) in patients after kidney transplantation made it possible to achieve significant results in reducing the number of acute rejection of kidney in recipients, and increasing the long-term survival of transplant ...
V. N. Lesovoy +2 more
doaj +1 more source
Pharmacoeconomic analysis of antineoplastics at the Oncology Institute of Vojvodina from 2005 to 2008 [PDF]
Contemporary cancer chemotherapy need to be active against malignant cell (selectivity), to be based on the molecular biology of the cancer cell, to enhance immune response to cancer, and to stop development of resistance to drug.
Ilić Maja S.
doaj +1 more source
High growth firms, innovation and competition: the case of the US pharmaceutical industry [PDF]
Innovation is key to economic growth. But firms, across sectors and regions, are highly skewed in their ability to engage with innovation, and even more skewed in their ability to translate investments in innovation into higher growth.
Mazzucato, Mariana, Parris, Stuart
core +2 more sources
Proposing a Comprehensive Model for Evaluating Human Resources Accounting Using Grounded Theory and Meta-Synthesis in Pharmaceutical Companies [PDF]
Introduction: Given the significant role of human resource accounting in organizations and institutions and the direct impact this branch of accounting has on organizational longevity, this research aims to provide a contextual model.
Hojjatollah Hajirezaie +2 more
doaj +1 more source
Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry [PDF]
Patent holders frequently attempt to mitigate the loss of monopoly power by authorizing generic entry prior to patent expiry (early entry). Competition in off-patent pharmaceutical markets may be adversely affected if early entry substantially impairs ...
Appelt, Silvia
core +4 more sources
Study of medicines’ market for the treatment of seborrheic dermatitis of the pilar part of head
Modern arsenal of medicines and cosmetics used for the therapy of seborrheic dermatitis of the pilar part of head is various enough. Today pharmaceutical market keeps developing and constitutes a complex system that causes the necessity of its ...
V. A. Solodovnik +3 more
doaj +1 more source
Why licensing authorities need to consider the net value of new drugs in assigning review priorities: Addressing the tension between licensing and reimbursement [PDF]
Pharmaceutical regulators and healthcare reimbursement authorities operate in different intellectual paradigms and adopt very different decision rules. As a result, drugs that have been licensed are often not available to all patients who could benefit ...
Angell +6 more
core +1 more source
A metal halide perovskite‐based photoanode integrated with a CoNiFe layered double hydroxide (LDH) cocatalyst is reported for selective glucose oxidation reaction (GOR), achieving simultaneous and unassisted photoelectrochemical hydrogen production. This system delivers high photocurrent density, excellent Faradaic efficiency of GOR, and strong techno ...
Shujie Zhou +12 more
wiley +1 more source
In Brazil, 80% of hypertensive patients have no blood pressure controlled, this fact has caused severe financial consequences for the public health system (PHS) and the Pharmaceutical Care (PC) has emerged as an effective alternative.
Maurílio de Souza Cazarim +2 more
doaj +1 more source

